Oncologists' attitudes toward KRAS testing: a multisite study

Recent discoveries promise increasingly to help oncologists individually tailor anticancer therapy to their patients’ molecular tumor characteristics. One such promising molecular diagnostic is Kirsten ras (KRAS) tumor mutation testing for metastatic colorectal cancer (mCRC) patients. In the current...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Harris, Julie N, Liljestrand, Petra, Alexander, Gwen L, Goddard, Katrina A B, Kauffman, Tia, Kolevska, Tatjana, McCarty, Catherine, O'Neill, Suzanne, Pawloski, Pamala, Rahm, Alanna, Williams, Andrew, Somkin, Carol P
Materialtyp: Artigo
Språk:Inglês
Publicerad: Blackwell Publishing Ltd 2013
Ämnen:
Clinical Cancer Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3892392/
https://ncbi.nlm.nih.gov/pubmed/24403261
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.135
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk